<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02442622</url>
  </required_header>
  <id_info>
    <org_study_id>14-01059</org_study_id>
    <nct_id>NCT02442622</nct_id>
  </id_info>
  <brief_title>Effectiveness of Astym Treatment For de Quervain's Tenosynovitis</brief_title>
  <official_title>Effectiveness of Astym Treatment For de Quervain's Tenosynovitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>New York University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine if the addition of Astym treatment to traditional therapy produces a more
      positive outcome then traditional therapy alone for the treatment of de Quervain's
      tenosynvitis. Two groups will be examined with one group receiving traditional therapy and
      the other group receiving traditional therapy in addition to Astym treatment protocol.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2015</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Numeric Rating Scale for Pain</measure>
    <time_frame>4.5 months</time_frame>
    <description>This scale is a single point scale from 0-10. The participant picks one number to represent their pain, where 0 represents no pain and 10 represents worst pain imaginable.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sequential Occupational Dexterity Assessment</measure>
    <time_frame>1.5 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quick Dash</measure>
    <time_frame>4.5 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>de Quervain's Disease</condition>
  <arm_group>
    <arm_group_label>Occupational therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Traditional therapy for de Quervain's Tenosynovitis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Occupational therapy with ASTYM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Traditional therapy for de Quervain's Tenosynovitis plus ASTYM</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Occupational therapy</intervention_name>
    <description>Occupational therapy for de Quervain's Tenosynovitis</description>
    <arm_group_label>Occupational therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Occupational therapy with ASTYM</intervention_name>
    <description>Occupational therapy for de Quervain's Tenosynovitis plus ASTYM</description>
    <arm_group_label>Occupational therapy with ASTYM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        i. Positive Finkelstein's test: The client will report pain over the first compartment of
        the extensor retinaculum when the thumb is tucked in the hand and deviated ulnarly.

        ii. Persistent symptoms for &gt;3 wks which have not resolved after an additional 3 weeks of
        splinting

        iii. A diagnosis by a physician of &quot;de Quervain's&quot;, &quot;fist compartment tenosynovitis&quot;, or
        &quot;radial styloid tenosynovitis&quot;

        iv. Patients must agree and comply to a predetermined splinting regimen

        Exclusion Criteria:

        i. History of cortical steroid injection to affected wrist and/or thumb

        ii. History of previous wrist trauma to affected limb

        iii. Comorbidity such as carpal tunnel syndrome (CTS), radial tunnel syndrome,
        osteoarthritis, rheumatoid arthritis, auto-immune disease or inflammatory conditions,
        lateral epicondylitis or tendinopathies

        iv. Clotting deficits

        v. Positive Cozen's sign which would indicate intersection syndrome

        vi. Post-partum mothers &lt;6 months and pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen VanLew, MS, OTR/L</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYU Langone Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>April O'Connell, OTR/L, CHT</last_name>
    <phone>(646) 501-7077</phone>
    <email>April.Davis@nyumc.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>NYU Langone Medical Center, Center for Musculoskeletal Care</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>April O'Connell, OTR/L,CHT</last_name>
      <phone>646-501-7707</phone>
      <email>April.Davis@nyumc.org</email>
    </contact>
    <contact_backup>
      <last_name>Daniel Geller, MS,MPH,OTR/L</last_name>
      <phone>646-501-7753</phone>
      <email>daniel.geller@nyumc.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 8, 2015</study_first_submitted>
  <study_first_submitted_qc>May 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 13, 2015</study_first_posted>
  <last_update_submitted>May 8, 2018</last_update_submitted>
  <last_update_submitted_qc>May 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>de Quervain's disease</keyword>
  <keyword>de Quervain's tenosynovitis.</keyword>
  <keyword>ASTYM</keyword>
  <keyword>de Quervain's treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tenosynovitis</mesh_term>
    <mesh_term>De Quervain Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

